In addition, GWAS studies also identified non-lipid mediated CAD risk loci where the mutations of genes involved in vascular endothelial cell repair, smooth muscle cell proliferation, migration, and remodeling also increases the risk of CAD without abnormal elevation of the plasma apoB-LPs [5,6,7]. This evidence concerns the gene APOB and coronary artery disorder.